genomic footprinting for predicting the clinical response to cancer therapy in colorectal cancer.

• 1. 患有炎症疾病的受试者对细胞因子靶向药物(CyTD)的早期反应或无反应预测的基因和基因组合 [P] . 中国专利： CN102918165A . 2013-02-06
• 2. 使用组合的基因组和临床风险评估预测自杀倾向 [P] . 中国专利： CN108291259A . 2018-07-17
• 3. genomic footprinting for predicting the clinical response to cancer therapy in colorectal cancer. [P] . ES2393709B1 . 2014-03-04

  机译： 基因组足迹技术可预测结直肠癌对癌症治疗的临床反应。

• 4. METHOD FOR PREDICTING THE CLINICAL RESPONSE TO CHEMOTHERAPY IN A SUBJECT WITH CANCER. [P] . MX2013015286A . 2014-09-25

  机译： 在癌症患者中预测对化学疗法的临床反应的方法。

• 5. GENOME FINGERPRINT FOR PREDICTING THE CLINICAL RESPONSE TO ANTI-TUMOR THERAPY IN COLORECTAL CANCER [P] . 世界知识产权组织专利： WO2012160235A1 . 2012-11-29

  机译： 基因组指纹预测大肠癌对肿瘤治疗的临床反应

• 1. Pathologic response after preoperativer therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases [J] . Yun Wang, Zhen-Hai Lu, Zhi-Zhong Pan, 癌症（英文版） . 2017,第011期
• 2. Clinical parameters predicting pathologic complete response followingneoadjuvant chemoradiotherapy forrectal cancer [J] . WeiGenZeng, JianWeiLiang, ZhengWang, 癌症（英文版） . 2015,第010期
• 3. Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer. [J] . Lee JK, Coutant C, Kim YC, Clinical cancer research: an official journal of the American Association for Cancer Research . 2010,第2期
• 4. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. [J] . Hatzis C, Pusztai L, Valero V, JAMA: the Journal of the American Medical Association . 2011,第18期
• 5. Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer. [J] . Han S, Park K, Shin E, Oncology reports . 2010,第1期
• 6. Predicting Response to Chemotherapy in Colorectal Cancer using Selected Reaction Monitoring [C] . Matthew McKay, Sarah Randall, Dana Pascovici, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010
• 7. Investigating the multi-targeted anti-cancer and chemopreventive potential of GSE in pre-clinical models of colorectal cancer. [D] . Derry, Molly M. 2013
• 8. In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer [O] . Hye Youn Kwon, Im-kyung Kim, Jeonghyun Kang, 2016
• 9. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. [O] . Siena Salvatore, Sartore-Bianchi Andrea, Di Nicolantonio Federica, 2009

• 1. Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy [J] . Qian-Qian Yu ,Hong Qiu ,Ming-Sheng Zhang . 世界胃肠病学杂志：英文版 . 2016,第16期
• 2. Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients [J] . Inti Zlobec ,Francesca Molinari ,Vittoria Martin . 世界胃肠病学杂志：英文版 . 2010,第38期
• 3. Clinical Predictors of Cetuximab for First-Line Therapy of Metastatic Colorectal Cancer: A Single Institutional Retrospective Study [J] . Yuki Morishita ,Hiroaki Tanioka ,Motoi Asano . 癌症治疗（英文） . 2017,第9期
• 4. 利用系统发生足迹技术寻找巴西固氮螺菌基因组上的功能特征——基于客户/服务器模式的多机并行实现 [C] . 姜平 . 2006年全国高性能计算学术会议（HPC 2006） . 2006
• 5. 基于SNP芯片技术的结直肠癌全基因组罕见拷贝数变异研究及相关基因的临床意义探索 [A] . 李振丽 . 2016